Healthcare · Drug Manufacturers - Specialty & Generic
No live calls today · full consensus board · graded history
Price (daily close, 2026-08-24)
Recent news
| 2026-08-23 | $XERS Princess! Get ready for a magical week....) · stocktwits |
| 2026-08-21 | $XERS strange brew here folks!!! · stocktwits |
| 2026-08-20 | $XERS Summary Xeris Biopharma Holdings, Inc. achieved record 2024 revenues of $203M, up 24%, with robust growth across all three commercial products. 2025 revenue guidance of $255M–$275M implies 30% growth for XERS at midpoint, supporting a forward P/S ratio of ~3.4x and fair · stocktwits |
| 2026-08-20 | Xeris Biopharma: A Commercial Stage Pharma That May Be A Slow-Burn Buy Opportunity · seeking_alpha |
| 2026-08-20 | $XERS Sept 9 Levo should mark the beginning of a new era at $10+ · stocktwits |
| 2026-08-19 | $XERS cannot be held down. 22 and beyond inevitable. · stocktwits |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。